Lukas Biomedical (6814) Stock Overview

Lukas Biomedical Inc. engages in the research and the development of immune cell therapy for cancer treatment. The company operates through three divisions: E-commerce, Medical Management Business, and Cell Product. It develops immune and stem cell medical technologies for regenerative medicine; wholesales and retails cosmetics; and wholesales medical equipment. The company was founded in 2002 and is based in Taipei, Taiwan.